Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 1998 Jan 5;187(1):123–128. doi: 10.1084/jem.187.1.123

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).

PMC Copyright notice

Lack of FasL influences neither the ability of gld CTLs to proliferate to wild-type levels after stimulation by optimal levels of plate-bound anti-CD3 antibodies nor their ability to perform cytolytic activity on a per recovered cell basis. (a) [³H]TdR incorporation by the long-term CTL lines used in Fig. 1 a, cultured over plate-bound anti-CD3 antibodies. Data are presented as in Fig. 1. (b) The same CTL responders were assayed for their ability to lyse ⁵¹Cr-labeled EL4 (H-2^b, open symbols) and R1.1 (H-2^k, filled symbols) tumor targets in a 4 h chromium release assay.